Skin and nail fungi—almost beaten: Don't get confused by the “evidence”

BMJ

Volumn 319, Issue 7202, 1999, Pages 71-72

  Finlay, Andrew Y ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; ITRACONAZOLE; TERBINAFINE; ANTIFUNGAL AGENT; GRISEOFULVIN; NAPHTHALENE DERIVATIVE;

CHILD; EDITORIAL; HUMAN; MYCOSIS; NAIL INFECTION; PRIORITY JOURNAL; SKIN INFECTION; TOPICAL DRUG ADMINISTRATION; ADULT; DERMATOMYCOSIS; NOTE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; CHILD; DERMATOMYCOSES; GRISEOFULVIN; HUMANS; NAPHTHALENES; ONYCHOMYCOSIS;

EID: 0033542510     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.319.7202.71     Document Type: Editorial

References (10)

1. Evans EGV, Sigurgeirsson B for the LION study group. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. BMJ 1999; 318: 1031–1035.
2. Hart R, Bell-Syer S, Crawford F, Torgerson DJ, Young P, Russell R. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ 1999; 319: 79–82.
3. Evans EGV. A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canestan) 1% cream given for four weeks in the treatment of tinea pedis. Br J Dermatol 1994; 130: 2–4.
4. Hill S, Thomas R, Smith SG, Finlay AY. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream. Br J Dermatol 1992; 127: 396–400.
5. Ellis DH, Watson AB, Marley JE, Williams TG. Non-dermatophytes in onychomycosis of the toenails. Br J Dermatol 1997; 136: 490–493.
6. Roberts DT, Evans EGV. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998; 138: 189–190.
7. Jones TC. Overview of the use of terbinafine in children. Br J Dermatol 1995; 132: 683–689.
8. Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada—a multicenter survey of 2001 patients. Internat J Dermatol 1997; 36: 783–787.
9. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exper Dermatol 1997; 22: 87–89.
10. Roberts DT. Systemic antifungals as a cause of liver damage. Prescribers Journal 1998; 38: 190–194.